FDA recalls 233,000 bottles of NJ drug for cancer risk

๐Ÿ’Š Drug company in East Brunswick issues recall

๐Ÿ’Š Chemical linked to cancer detected in antidepressant

๐Ÿ’Š Could be found in other medications

EAST BRUNSWICK โ€” A New Jersey pharmaceutical company is recalling more than 230,000 bottles of antidepressants after detecting a chemical that can cause cancer.

The recall impacts duloxetine sold by Rising Pharmaceuticals. Duloxetine is a delayed-release medication that is often prescribed to treat depression and generalized anxiety disorder.

Headquartered in East Brunswick, Rising Pharmaceuticals issued the voluntary recall on Nov. 19…

Story continues

YOU MIGHT ALSO LIKE

TRENDING ARTICLES